Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Jane

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Blood Cancer Journal|August 9, 2014
Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemiaK D Cummins, S M Jane, S Ninkovic, et al.
Leukemia|April 28, 2016
Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signallingC S Tremblay, F C Brown, M Collett, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Blood Cancer Journal|August 9, 2014
Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemiaK D Cummins, S M Jane, S Ninkovic, et al.
Leukemia|April 28, 2016
Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signallingC S Tremblay, F C Brown, M Collett, et al.
Pageof 5